ALPHA — Pharnext SCA Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Pharnext announces findings evaluating Charcot-Marie-Tooth Neuropathy Score
Brief: Pharnext amends liquidity contract with broker Gilbert Dupont
Brief: Pharnext completes patient enrollment in Pivotal Phase 3 trial of PXT3003 for Charcot-Marie-Tooth Disease Type 1a
Brief: Pharnext presents positive exploratory Phase 2 data from clinical trials on Alzheimer
Brief: Pharnext: DSMB recommends continuing ongoing phase 3 trial of PXT3003
Brief: Pharnext H1 net loss widens to 8.0 mln euros
Brief: Pharnext confirms support for Hereditary Neuropathy Foundation